TherapeuticsMD Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 02/13/2026 | 1.19 M | $1.94 M | 0.00% | 10.30% |
| CLEARLINE CAPITAL LP | 02/17/2026 | 635.22 K | $1.04 M | 0.00% | 5.49% |
| VANGUARD GROUP INC | 01/29/2026 | 397.06 K | $647.20 K | 5.37% | 3.43% |
| TEJARA CAPITAL LTD | 02/05/2026 | 350.85 K | $571.89 K | 1.93% | 3.03% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 209.21 K | $341.01 K | 0.00% | 1.81% |
| MORGAN STANLEY | 02/13/2026 | 129.22 K | $210.62 K | -1.04% | 1.12% |
| BLACKROCK, INC. | 02/12/2026 | 116.13 K | $189.30 K | 0.00% | 1.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 106.10 K | $172.98 K | -2.73% | 0.92% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 96.50 K | $157.30 K | 171.83% | 0.83% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 35.16 K | $57.32 K | 100.00% | 0.30% |
| STATE STREET CORP | 02/13/2026 | 30.10 K | $49.06 K | 0.00% | 0.26% |
| CITADEL ADVISORS LLC | 02/17/2026 | 28.24 K | $46.03 K | -17.60% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 24.10 K | $39.28 K | 100.00% | 0.21% |
| CITADEL ADVISORS LLC | 02/17/2026 | 20.60 K | $33.58 K | 100.00% | 0.18% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 17.00 K | $27.71 K | -50.00% | 0.15% |
| NORTHERN TRUST CORP | 02/17/2026 | 16.45 K | $26.81 K | -0.05% | 0.14% |
| JANE STREET GROUP, LLC | 02/12/2026 | 12.20 K | $19.89 K | 100.00% | 0.11% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 9.30 K | $15.15 K | 936.45% | 0.08% |
| FMR LLC | 02/17/2026 | 8.29 K | $13.51 K | 0.01% | 0.07% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 2.47 K | $4.03 K | -9.59% | 0.02% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 1.60 K | $2.60 K | 100.00% | 0.01% |
| UBS GROUP AG | 01/29/2026 | 1.11 K | $1.82 K | 207.73% | 0.01% |
| NATIONAL BANK OF CANADA /FI/ | 02/17/2026 | 610 | $976 | -8.96% | 0.01% |
| SMARTLEAF ASSET MANAGEMENT LLC | 02/13/2026 | 601 | $986 | 100.00% | 0.01% |
| JPMORGAN CHASE & CO | 02/11/2026 | 293 | $477 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 255 | $416 | 0.00% | 0.00% |
| US BANCORP \DE\ | 01/30/2026 | 246 | $401 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 226 | $368 | 0.00% | 0.00% |
| HUNTINGTON NATIONAL BANK | 02/09/2026 | 120 | $196 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 108 | $176 | 1.89% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 01/30/2026 | 40 | $65 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 37 | $60 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/12/2026 | 35 | $57 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 01/23/2026 | 30 | $49 | 0.00% | 0.00% |
| IFP ADVISORS, INC | 02/06/2026 | 21 | $34 | 0.00% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2026 | 20 | $33 | 100.00% | 0.00% |
| PROVENANCE WEALTH ADVISORS, LLC | 01/26/2026 | 20 | $33 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 02/13/2026 | 10 | $16 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 02/09/2026 | 8 | $13 | 0.00% | 0.00% |
| ASSETMARK, INC | 01/23/2026 | 4 | $7 | 0.00% | 0.00% |
| SMALLWOOD WEALTH INVESTMENT MANAGEMENT, LLC | 01/23/2026 | 2 | $3 | 0.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 1 | $2 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/06/2026 | 1 | $2 | 0.00% | 0.00% |
| STRATEGIC ADVOCATES LLC | 02/11/2026 | 1 | $2 | 0.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| J. GOLDMAN & CO LP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 02/18/2026 | 0 | $0 | -100.00% | 0.00% |
| WEALTH WATCH ADVISORS, INC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
TherapeuticsMD Inc institutional Ownership - FAQ's
During the previous two years, 52 institutional investors and hedge funds held shares of TherapeuticsMD Inc. The most heavily invested institutionals were:
UBS Group AG: 331
SBI Securities Co., Ltd.: 267
Activest Wealth Management: 40
Farther Finance Advisors, LLC: 31
IFP Advisors, Inc: 21
Provenance Wealth Advisors, LLC: 20
29.25% of TherapeuticsMD Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.56 M shares in the last 24 months. This purchase volume represents approximately $8.19 M in transactions.